The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic and immune landscape of biliary tract cancers with ARID1A, PBRM1, and BAP1 alterations.
 
Gentry Teng King
Consulting or Advisory Role - Novartis; Pfizer; QED Therapeutics; Tempus; Zymeworks
Research Funding - Bayer (Inst)
 
Rachel Berg
Employment - Tempus
 
Binyam Yilma
Employment - Tempus
Consulting or Advisory Role - Analysis Group
 
Melissa Conrad Stoppler
Employment - Gilead Sciences (I); Roche/Genentech (I); Roche/Genentech (I); Tempus
Stock and Other Ownership Interests - Exact Sciences; Gilead Sciences (I); Roche/Genentech (I); Tempus
 
Ronan Wenhan Hsieh
No Relationships to Disclose
 
Rachael A Safyan
Honoraria - Curio Science; Guardant Health
Research Funding - Merck (Inst)
 
David Bing Zhen
Consulting or Advisory Role - Cornerstone Pharmaceuticals; Ipsen; Jazz Pharmaceuticals
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Cornerstone Pharmaceuticals (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Genentech (Inst); Legend Biotech (Inst); Lilly (Inst); Merck (Inst); Seagen (Inst); TME Pharma (Inst)
 
Andrew L. Coveler
Consulting or Advisory Role - Abbvie; Halozyme; Merrimack; Seagen
Research Funding - AbGenomics International (Inst); Actuate Therapeutics (Inst); Amgen (Inst); Amgen (Inst); AstraZeneca (Inst); Genentech (Inst); Gilead Sciences (Inst); Halozyme (Inst); Immunomedics (Inst); Lilly (Inst); Newlink Genetics (Inst); Nextrast (Inst); Novocure (Inst); Nucana (Inst); Onconova Therapeutics (Inst); Seagen (Inst); Surface Oncology (Inst); Taiho Pharmaceutical (Inst); XBiotech (Inst)
Travel, Accommodations, Expenses - Abbvie; Halozyme; Nucana
 
Stacey A. Cohen
Consulting or Advisory Role - Bayer; Delcath Systems; Eisai; Pfizer; Regeneron; Taiho Oncology
Research Funding - Biomea (Inst); BioNTech SE (Inst); Natera; Pfizer (Inst); Tempus (Inst)
Expert Testimony - Evans, Craven & Lackie
Travel, Accommodations, Expenses - Biomea Fusion; Natera
 
Veena Shankaran
Honoraria - Cambia Health Foundation
Research Funding - Amgen (Inst); Apexigen (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck (Inst)
 
E. Gabriela Chiorean
Consulting or Advisory Role - Astellas Pharma; Axiom Healthcare Strategies; Bayer; Bristol-Myers Squibb/Celgene; Cardiff Oncology; Foundation Medicine; G1 Therapeutics; IgM Biosciences; Ipsen; Merck; Merus; Novartis; Pfizer; Stemline Therapeutics
Research Funding - AADi (Inst); BioMed Valley Discoveries (Inst); Boehringer Ingelheim (Inst); Erasca, Inc; FibroGen (Inst); Gilead/Forty Seven; Lonza (Inst); Merck (Inst); Novartis; Rafael Pharmaceuticals (Inst); Roche (Inst); Stemline Therapeutics (Inst)
Travel, Accommodations, Expenses - G1 Therapeutics
 
William Proctor Harris
Consulting or Advisory Role - Boston Scientific; ICON Clinical Research; Merck
Research Funding - Bayer (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Koo Foundation (Inst); MedImmune (Inst); Merck (Inst); Sanofi Pasteur (Inst); zymeworks (Inst)
Expert Testimony - Boston Scientific; Merck